A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers

Description

This study is designed to determine if a dieatary supplement containing beta-glucan can reduce the incidence, severity and duration of upper respiratory tract infections among a group of highly trained athletes

Conditions

Upper Respiratory Tract Infections, Mental Stress

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is designed to determine if a dieatary supplement containing beta-glucan can reduce the incidence, severity and duration of upper respiratory tract infections among a group of highly trained athletes

A Clinical Study to Determine if Beta-glucan Reduces the Incidence, Duration or Severity of Upper Respiratory Tract Infections Among Skiers

A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers

Condition
Upper Respiratory Tract Infections
Intervention / Treatment

-

Contacts and Locations

Park City

US Ski and Snowboard Center of Excellence, Park City, Utah, United States, 84060

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provide informed consent by signing the electronic Information and Consent Form.
  • * Male or females between the ages of 18 and 30 (inclusive) without regard to race or ethnic background
  • * Are in generally good health and have no medical conditions that would prevent or interfere with their participation in the study
  • * Are fully able and willing to comply with the requirements of the study
  • * Are fully able and willing to keep scheduled appointments
  • * Females that are pregnant, attempting to become pregnant or are currently lactating/nursing a child.
  • * Individuals currently taking prescription medications that are known to be immunosuppressants (e.g. dexamethasone, tacrolimus, methotrexate)
  • * Individuals with gastrointestinal conditions (e.g., inflammatory bowel disease, Crohn's disease, etc.) that may affect consumption of the treatment supplements.
  • * Individuals with clinically important renal, hepatic, cardiac pulmonary, pancreatic, neurologic or biliary disorders; insulin-dependent and orally controlled diabetics will also be excluded from the study.
  • * Individuals with a recent history of cancer other than non-melanoma skin cancer.
  • * Individual's that have trouble swallowing pills.
  • * Individuals that have participated as a subject in any other clinical study within 30 days of screening.
  • * Individuals with a history of alcohol abuse or other substance abuse within the previous 2 years.
  • * Individuals that currently use tobacco products including chewing tobacco and cigarettes.

Ages Eligible for Study

18 Years to 30 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

USANA Health Sciences,

Mark Levy, PhD, PRINCIPAL_INVESTIGATOR, USANA Health Sciences

Study Record Dates

2023-12-31